|
|
|
Volumn 25, Issue 5 SUPPL., 1998, Pages 39-46
|
|
Efficacy and toxicity of irinotecan in patients with colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
FLUOROURACIL;
IRINOTECAN;
LOPERAMIDE;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NAUSEA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
VOMITING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CAMPTOTHECIN;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
DNA TOPOISOMERASES, TYPE I;
HUMANS;
NEOPLASM METASTASIS;
SALVAGE THERAPY;
|
|
EID: 0031754985
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (62)
|
|
References (24)
|
